会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Ambulatory repeater for use in automated patient care
    • 动态中继器,用于自动化病人护理
    • US08216135B2
    • 2012-07-10
    • US13095204
    • 2011-04-27
    • Donald L. GoschaLisa D. HaederVeerichetty A. KadhiresanDavid C. JohnsonMuralidharan SrivathsaMarina Brockway
    • Donald L. GoschaLisa D. HaederVeerichetty A. KadhiresanDavid C. JohnsonMuralidharan SrivathsaMarina Brockway
    • A61B5/00
    • A61B5/0031G06F19/00
    • An ambulatory repeater for use in automated patient care is presented. A local memory store includes a cryptographic key, sensitive information, and physiological measures. The cryptographic key is uniquely assigned to the implantable medical device prior to implant of the implantable medical device into a patient. The sensitive information is preencrypted under the cryptographic key and physiological measures are measured by the implantable medical device. An authentication module is in receipt of the cryptographic key. A permissions module confirms authorization of an external data processing device against the cryptographic key. A decryption module decrypts the sensitive information with the cryptographic key into decrypted information. A processor is operatively coupled to the local memory store. A communications module exchanges the decrypted information and the physiological measures with the external data processing device over a wireless interface contingent upon the authorization confirmation. An internal power supply supplies power to the foregoing components.
    • 提出了一种用于自动病人护理的移动中继器。 本地存储器包括加密密钥,敏感信息和生理措施。 在将可植入医疗装置植入病人之前,将密码密钥唯一地分配给可植入医疗装置。 敏感信息在加密密钥下加密,生理测量由可植入医疗设备测量。 认证模块正在接收加密密钥。 权限模块根据加密密钥确认外部数据处理设备的授权。 解密模块将具有加密密钥的敏感信息解密为解密信息。 处理器可操作地耦合到本地存储器存储器。 通信模块根据授权确认,通过无线接口与外部数据处理装置交换解密信息和生理测量。 内部电源为上述组件供电。
    • 3. 发明申请
    • AMBULATORY REPEATER FOR USE IN AUTOMATED PATIENT CARE
    • 在自动化患者护理中使用的辅助重复器
    • US20110200194A1
    • 2011-08-18
    • US13095204
    • 2011-04-27
    • Donald L. GoschaLisa D. HaederVeerichetty A. KadhiresanDavid C. JohnsonMuralidharan SrivathsaMarina Brockway
    • Donald L. GoschaLisa D. HaederVeerichetty A. KadhiresanDavid C. JohnsonMuralidharan SrivathsaMarina Brockway
    • H04L9/28H04L9/08
    • A61B5/0031G06F19/00
    • An ambulatory repeater for use in automated patient care is presented. A local memory store includes a cryptographic key, sensitive information, and physiological measures. The cryptographic key is uniquely assigned to the implantable medical device prior to implant of the implantable medical device into a patient. The sensitive information is preencrypted under the cryptographic key and physiological measures are measured by the implantable medical device. An authentication module is in receipt of the cryptographic key. A permissions module confirms authorization of an external data processing device against the cryptographic key. A decryption module decrypts the sensitive information with the cryptographic key into decrypted information. A processor is operatively coupled to the local memory store. A communications module exchanges the decrypted information and the physiological measures with the external data processing device over a wireless interface contingent upon the authorization confirmation. An internal power supply supplies power to the foregoing components.
    • 提出了一种用于自动病人护理的移动中继器。 本地存储器包括加密密钥,敏感信息和生理措施。 在将可植入医疗装置植入病人之前,将密码密钥唯一地分配给可植入医疗装置。 敏感信息在加密密钥下加密,生理测量由可植入医疗设备测量。 认证模块正在接收加密密钥。 权限模块根据加密密钥确认外部数据处理设备的授权。 解密模块将具有加密密钥的敏感信息解密为解密信息。 处理器可操作地耦合到本地存储器存储器。 通信模块根据授权确认,通过无线接口与外部数据处理装置交换解密信息和生理测量。 内部电源为上述组件供电。
    • 4. 发明授权
    • Ambulatory repeater for use in automated patient care
    • 动态中继器,用于自动化病人护理
    • US07967751B2
    • 2011-06-28
    • US11893704
    • 2007-08-17
    • Donald L. GoschaLisa D. HaederVeerichetty A. KadhiresanDavid C. JohnsonMuralidharan SrivathsaMarina Brockway
    • Donald L. GoschaLisa D. HaederVeerichetty A. KadhiresanDavid C. JohnsonMuralidharan SrivathsaMarina Brockway
    • A61B5/00
    • A61B5/0031G06F19/00
    • An ambulatory repeater for use in automated patient care is presented. A local memory store includes a cryptographic key, sensitive information, and physiological measures. The cryptographic key is uniquely assigned to the implantable medical device prior to implant of the implantable medical device into a patient. The sensitive information is preencrypted under the cryptographic key and physiological measures are measured by the implantable medical device. An authentication module is in receipt of the cryptographic key. A permissions module confirms authorization of an external data processing device against the cryptographic key. A decryption module decrypts the sensitive information with the cryptographic key into decrypted information. A processor is operatively coupled to the local memory store. A communications module exchanges the decrypted information and the physiological measures with the external data processing device over a wireless interface contingent upon the authorization confirmation. An internal power supply supplies power to the foregoing components.
    • 提出了一种用于自动病人护理的移动中继器。 本地存储器包括加密密钥,敏感信息和生理措施。 在将可植入医疗装置植入病人之前,将密码密钥唯一地分配给可植入医疗装置。 敏感信息在加密密钥下加密,生理测量由可植入医疗设备测量。 认证模块正在接收加密密钥。 权限模块根据加密密钥确认外部数据处理设备的授权。 解密模块将具有加密密钥的敏感信息解密为解密信息。 处理器可操作地耦合到本地存储器存储器。 通信模块根据授权确认,通过无线接口与外部数据处理装置交换解密信息和生理测量。 内部电源为上述组件供电。
    • 7. 发明授权
    • Heart rate variability as an indicator of exercise capacity
    • 心率变异性作为运动能力的指标
    • US06529772B2
    • 2003-03-04
    • US09888726
    • 2001-06-25
    • Gerrard M. CarlsonVeerichetty A. KadhiresanJulio C. Spinelli
    • Gerrard M. CarlsonVeerichetty A. KadhiresanJulio C. Spinelli
    • A61B504
    • A61N1/365A61B5/0245A61B5/222A61N1/3627A61N1/36514A61N1/36592
    • Based upon patient studies indices a high degree of correlation was found between HRV and VO2max, i.e., the patient's exercise capacity. Based on this finding, a pacing therapy optimization protocol for treating patients with CHF has been devised. The protocol involves first pacing the patient's heart with a pacemaker programmed to operate in a first mode for a predetermined time period and then collecting electrogram data from which a HRV index is derived. The mode is then changed and the steps repeated until all possible modes have been utilized. At that time, a determination is made as to which of the modes is associated with the largest HRV index and the pacemaker is then programmed to function in that mode. Alternatively, the method of the present invention can be applied to changes in drug therapy instead of or in combination with pacing therapy. By the plotting the HRV index computed in the manner described, the efficacy of a change in therapy on patient exercise capacity can be assessed.
    • 根据患者研究指标,发现HRV和VO2max之间存在高度相关性,即患者的运动能力。 基于这一发现,已经设计了用于治疗CHF患者的起搏治疗优化方案。 该方案涉及首先用编程为在第一模式中操作预定时间段的起搏器起搏患者的心脏,然后收集从其导出HRV指数的电描记图数据。 然后改变模式,重复步骤直到所有可能的模式被使用。 此时,确定哪个模式与最大HRV指数相关联,并且起搏器然后被编程为在该模式下起作用。 或者,本发明的方法可以应用于药物治疗的变化,而不是起搏治疗或与起搏治疗组合。 通过绘制以所述方式计算的HRV指数,可以评估治疗改变对患者运动能力的功效。
    • 9. 发明授权
    • Heart rate variability as an indicator of exercise capacity
    • 心率变异性作为运动能力的指标
    • US06301499B1
    • 2001-10-09
    • US09419659
    • 1999-10-18
    • Gerrard M. CarlsonVeerichetty A. KadhiresanJulio C. Spinelli
    • Gerrard M. CarlsonVeerichetty A. KadhiresanJulio C. Spinelli
    • A61B50456
    • A61N1/365A61B5/0245A61B5/222A61N1/3627A61N1/36514A61N1/36592
    • Based upon patient studies indices a high degree of correlation was found between HRV and VO2max, i.e., the patient's exercise capacity. Based on this finding, a pacing therapy optimization protocol for treating patients with CHF has been devised. The protocol involves first pacing the patient's heart with a pacemaker programmed to operate in a first mode for a predetermined time period and then collecting electrogram data from which a HRV index is derived. The mode is then changed and the steps repeated until all possible modes have been utilized. At that time, a determination is made as to which of the modes is associated with the largest HRV index and the pacemaker is then programmed to function in that mode. Alternatively, the method of the present invention can be applied to changes in drug therapy instead of or in combination with pacing therapy. By the plotting the HRV index computed in the manner described, the efficacy of a change in therapy on patient exercise capacity can be assessed.
    • 根据患者研究指标,发现HRV和VO2max之间存在高度相关性,即患者的运动能力。 基于这一发现,已经设计了用于治疗CHF患者的起搏治疗优化方案。 该方案涉及首先用编程为在第一模式中操作预定时间段的起搏器起搏病人的心脏,然后收集从其导出HRV指数的电描记图数据。 然后改变模式,重复步骤直到所有可能的模式被使用。 此时,确定哪个模式与最大HRV指数相关联,并且起搏器然后被编程为在该模式下起作用。 或者,本发明的方法可以应用于药物治疗的变化,而不是起搏治疗或与起搏治疗组合。 通过绘制以所述方式计算的HRV指数,可以评估治疗改变对患者运动能力的功效。